In vitro and In vivo evaluation of phage-antibiotic synergy for the treatment of urinary tract infections
Microbial Pathogenesis · 2025
DOI: 10.1016/j.micpath.2025.108005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2025. Verfasst von Naveen Chaudhary und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India. Electronic address:…. Hauptthemen laut MEDLINE: Urinary Tract Infections, Anti-Bacterial Agents, Uropathogenic Escherichia coli, Phage Therapy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
The therapeutic challenges caused by multidrug-resistant (MDR) and extensively drug-resistant (XDR) bacteria have necessitated the development of alternative treatment strategies. Phage-antibiotic synergy (PAS) has recently emerged to replace or possibly supplement antibiotics. We isolated the lytic phage NTNC80A from hospital sewage in Chandigarh, India, and it belongs to the class Caudoviricetes of viruses. We tested multiple strategies to investigate the synergistic effects of phage and antibiotic combinations against highly drug-resistant uropathogenic Escherichia coli isolates. The maximum synergistic effects (ΣFIC ≤0.5) were observed when phage NTNC80A was combined with ciprofloxacin simultaneously. Cell filamentation, characterised by elongated and interconnected cells, was observed at the sub-inhibitory ciprofloxacin doses (1/4,1/10 of MIC). Ciprofloxacin could accelerate cell lysis by stimulating filamentation, disrupting the peptidoglycan layer and enhancing susceptibility to phage enzymes. Phenotypic changes in phage and antibiotic-resistant mutants indicate that bacteria become susceptible to antibiotics or phages when their growth rate, metabolism, or resistance gene expression is altered. The simultaneous strategy outperformed the sequential strategy by enhancing synergistic effects and minimising the risk of resistance development. A significant reduction (p < 0.01-0.001) in bacterial loads in urine, bladder, and kidneys was observed in mice treated with a combination of phage (106 PFU) and sub-inhibitory concentrations of ciprofloxacin. The optimized phage-antibiotic combination reduced tissue bacterial burden and enhanced animal survival rate, indicating improved PAS therapeutic effects. These findings have significant implications for the future of UTI treatment strategies, particularly in the context of growing antibiotic resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India. Electronic address: Chaudharynaveen.999@gmail.com.
- Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India. Electronic address: sandhu.preet205@gmail.com.
- Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India. Electronic address: vnmodgil@gmail.com.
- Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India. Electronic address: Dhruvjogi14@gmail.com.
- Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India. Electronic address: RKMAURYA9888@gmail.com.
- Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India. Electronic address: Balvindermohan2002@yahoo.com.
Förderung
- Indian Council of Medical Research
Zitieren
APA
Chaudhary, N., Kaur, H., Modgil, V., Singh, D., Maurya, R. K., Mohan, B., & Taneja, N. (2025). In vitro and In vivo evaluation of phage-antibiotic synergy for the treatment of urinary tract infections. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2025.108005
Vancouver
Chaudhary N, Kaur H, Modgil V, Singh D, Maurya RK, Mohan B, et al. In vitro and In vivo evaluation of phage-antibiotic synergy for the treatment of urinary tract infections. Microbial Pathogenesis. 2025. doi:10.1016/j.micpath.2025.108005
BibTeX
@article{Chaudhary2025,
author = {Chaudhary, Naveen and Kaur, Harpreet and Modgil, Vinay and Singh, Dharmender and Maurya, Ravi Kumar and Mohan, Balvinder and Taneja, Neelam},
title = {In vitro and In vivo evaluation of phage-antibiotic synergy for the treatment of urinary tract infections},
journal = {Microbial Pathogenesis},
year = {2025},
doi = {10.1016/j.micpath.2025.108005}
}
EUVIMED